Klotho Neurosciences (KLTO) Stock Statistics & Valuation Metrics

Klotho Neurosciences has a market cap or net worth of $23.40M. The enterprise value is $1.08B.

Klotho Neurosciences has 32,494,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Klotho Neurosciences’s return on equity (ROE) is -5.19 and return on invested capital (ROIC) is -373.94%.

The current PE Ratio of Klotho Neurosciences is -1.52. Klotho Neurosciences’s PEG ratio is -91.27.

In the last 12 months, Klotho Neurosciences had revenue of 0.00 and earned -6.15M in profits. Earnings per share was -0.32.

In the last 12 months, operating cash flow was -2.02M and capital expenditures 0.00, giving a free cash flow of -2.02M billion.

Klotho Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Klotho Neurosciences upcoming earnings date is ―, ―.

Klotho Neurosciences as a current ratio of 0.13, with Debt / Equity ratio of 256.64%

In the past 12 months, Klotho Neurosciences has paid 0.00 in taxes.

Klotho Neurosciences EV to EBITDA ratio is -1.65, with an EV/FCF ratio of -3.11.

Klotho Neurosciences has $63.74K in cash and marketable securities with $271.75K in debt, giving a net cash position of $208.01K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Klotho Neurosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―